CCMIC
Cardinal Capital Management Inc (Canada) Portfolio holdings
AUM
$3.19B
1-Year Return
20.91%
This Quarter Return
+12.29%
1 Year Return
+20.91%
3 Year Return
+37.51%
5 Year Return
+100.22%
10 Year Return
+118.29%
AUM
$1,000M
AUM Growth
+$147M
(+17%)
Cap. Flow
+$43.5M
Cap. Flow
% of AUM
4.35%
Top 10 Holdings %
Top 10 Hldgs %
50.87%
Holding
56
New
4
Increased
28
Reduced
15
Closed
–
Top Buys
| 1 |
Amgen
AMGN
|
+$16.8M |
| 2 |
Bank of America
BAC
|
+$10.8M |
| 3 |
Magna International
MGA
|
+$3.86M |
| 4 |
Enbridge
ENB
|
+$2.73M |
| 5 |
Canadian Natural Resources
CNQ
|
+$2M |
Top Sells
| 1 |
Cisco
CSCO
|
+$1.39M |
| 2 |
Telus
TU
|
+$850K |
| 3 |
Gildan
GIL
|
+$623K |
| 4 |
VF Corp
VFC
|
+$604K |
| 5 |
Honeywell
HON
|
+$487K |
Sector Composition
| 1 | Financials | 39.7% |
| 2 | Energy | 17.64% |
| 3 | Consumer Discretionary | 10.97% |
| 4 | Communication Services | 8.08% |
| 5 | Healthcare | 7.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Wells Fargo
WFC
$261B
| $16.5M | 1.65% |
340,613
+11,716
| +4% | +$566K |
|
27
PNC Financial Services
PNC
$79.5B
| $15.3M | 1.53% |
124,360
+5,255
| +4% | +$645K |
|
|
WBA
28
DELISTED
Walgreens Boots Alliance
WBA
| $15M | 1.5% |
236,855
+12,565
| +6% | +$795K |
|
29
CVS Health
CVS
$95.1B
| $13.9M | 1.39% |
258,450
+26,035
| +11% | +$1.4M |
|
30
Oracle
ORCL
$830B
| $12.1M | 1.21% |
224,523
+4,775
| +2% | +$256K |
|
|
31
Bank of America
BAC
$375B
| $10.8M | 1.08% |
+392,495
| New | +$10.8M |
|
32
Novartis
NVS
$240B
| $8.74M | 0.87% |
101,412
+2,159
| +2% | +$186K |
|
33
TSMC
TSM
$1.35T
| $7.94M | 0.79% |
193,832
+8,955
| +5% | +$367K |
|
34
Whirlpool
WHR
$5.15B
| $7.86M | 0.79% |
59,130
-245
| -0.4% | -$32.6K |
|
35
SAP
SAP
$299B
| $6.25M | 0.62% |
54,088
+4,300
| +9% | +$496K |
|
36
Merck
MRK
$207B
| $873K | 0.09% |
11,004
| – | – |
|
|
GRP.U
37
Granite Real Estate Investment Trust
GRP.U
$3.43B
| $815K | 0.08% |
17,050
+1,100
| +7% | +$52.6K |
|
38
Pfizer
PFE
$136B
| $739K | 0.07% |
18,340
| – | – |
|
39
Bristol-Myers Squibb
BMY
$94B
| $601K | 0.06% |
12,600
+200
| +2% | +$9.54K |
|
40
Fortis
FTS
$24.9B
| $456K | 0.05% |
12,350
+375
| +3% | +$13.8K |
|
41
BCE
BCE
$22.5B
| $164K | 0.02% |
3,700
-915
| -20% | -$40.6K |
|
42
Manulife Financial
MFC
$54.2B
| $42K | ﹤0.01% |
2,500
-800
| -24% | -$13.4K |
|
43
Nutrien
NTR
$27.7B
| $27K | ﹤0.01% |
520
| – | – |
|
44
Novo Nordisk
NVO
$244B
| $24K | ﹤0.01% |
900
| – | – |
|
45
Cenovus Energy
CVE
$30.4B
| $23K | ﹤0.01% |
2,650
| – | – |
|
46
Stantec
STN
$12.6B
| $17K | ﹤0.01% |
700
| – | – |
|
47
Thomson Reuters
TRI
$78B
| $13K | ﹤0.01% |
218
| – | – |
|
|
WBK
48
DELISTED
Westpac Banking Corporation
WBK
| $12K | ﹤0.01% |
650
| – | – |
|
49
Ovintiv
OVV
$10.8B
| $8K | ﹤0.01% |
210
-100
| -32% | -$3.81K |
|
50
RTX Corp
RTX
$209B
| $6K | ﹤0.01% |
79
| – | – |
|